Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2023
This course offers Live (in-person) and Livestream (virtual) attendance options
September 21 - 23, 2023 - The Westin Kierland - Scottsdale, Arizona
The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2023 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, opioid tapering and legal considerations, as well as medical and interventional alternatives to opioids. In addition, the course covers a broad range of issues, including opioid use disorder and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. This course includes lectures by experts in the field of pain medicine and opioid management as well as question and answer sessions.
This continuing education activity satisfies the new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners. Learners should claim only the credit commensurate with the extent of their participation in the activity.
This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including medical, surgical and outpatient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (nurse, pharmacist, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy.
Upon completion of this activity, participants should be able to:
- Review opioid practice updates and discuss how to implement a plan to appropriately monitor patients chronically using opioids.
- Define methods to taper opioids using a team based approach and the options for proper opioid disposal.
- Describe the use of methadone and buprenorphine in the management of chronic pain.
- Identify those with opioid use disorder and understand medications for opioid use disorder (MOUD).
- Determine and optimize treatment for patients suffering from pain and comorbid depression/anxiety.
- Explain how to apply best practice for non-opioid adjuvants, interventional pain therapies, and alternative pain modalities as part of a comprehensive multimodal pain management plan.
- Compare & contrast 2016 CDC opioid prescribing guidelines with updated guidelines in 2022.
- Describe the pitfalls and potential repercussions related to CDC guideline application.
- Identify the challenges involved in chronic opioid management: balancing patient safety, patient’s quality of life, and provider satisfaction .
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Guest rooms have been reserved for attendees and their guests with special course rates at the Westin Kierland, Scottsdale, AZ. To receive the special rate of $299 (plus applicable taxes and fees) for a standard room, reservations must be made before the room block is filled or before the expiration date of August 30th, 2023, whichever comes first. After August 30, 2023, reservations will be taken based on space and rate availability.
Run of the House Room - $299.00
Reservation can be made online.
Please identify yourself as a participant of the Mayo Clinic Opioid course when making your reservation. You may call (480) 624-1000 to make your reservation.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Julie L. Cunningham, Pharm.D., R.Ph.
My research work relates to elucidation of the genetic basis of disease. My primary focus is the genetic basis of familial cancer, in particular, cancers of the colon, prostate, ovary, NHL and CLL, breast and pancreas. As director of the Genotyping Shared Resource, I also participate in a number of research projects including Parkinson's Disease, Vaccine Research, Addiction and Pharmacogenetics. I work closely with individuals from biostatistics, epidemiology, and the Mayo Clinic Cancer and Genomics Centers.
Benjamin Lai, M.B., B.Ch., B.A.O.
Dr. Benjamin Lai is a Consultant and Assistant Professor in the Department of Family Medicine at Mayo Clinic. He serves as the Medical Director of Mayo’s Opioid Stewardship Program. He has led efforts to expand office-based buprenorphine treatment for opioid use disorder patients at Mayo Clinic and is involved in medical student and residency training. Dr. Lai is a member of Mayo’s Controlled Substance Advisory Group. Dr. Lai is currently a Population Health Science Scholar in the Mayo Clinic Robert D. and Patricia E. Kern Center for Science and Health Care Delivery. His clinical and research interests include chronic opioid therapy for non-cancer pain and treatment for opioid use disorder using medications for opioid use disorder.
Oludare (Dare) O. Olatoye, M.D.
Dr. Olatoye received his medical degree from Johns Hopkins School of Medicine, Baltimore Maryland in 2014. He completed his residency in Anesthesiology and fellowship in pain medicine both at the Mayo Clinic School of Medicine, Rochester Minnesota. He is board-certified through the American Board of Anesthesiology in Anesthesiology and Pain Medicine. Dr. Olatoye is currently a faculty member in the Division of Pain Medicine at the Mayo Clinic Rochester Minnesota where he serves as the Medical Director of the Inpatient Pain Service. He is an active member of the Spine interventional Society, North American Neuromodulation Society and American Academy of Pain Medicine.
Mayo Clinic Faculty
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Thursday (Optional Workshop)
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 17.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 17.75 knowledge-based contact hours. Participants should only claim credit commensurate with the extent of their participation in the activity.
Universal Activity Number (UAN): JA0000238-0000-23-111-L08-P.
The AAFP has reviewed Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2023, and deemed it acceptable for AAFP credit. Term of approval is from 09/21/2023 to 09/23/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 17.75 AAFP Prescribed
- 17.75 ACPE
- 17.75 AMA PRA Category 1 Credit™
- 17.75 ANCC
- 17.75 Attendance
In response to company inquiries, we are excited to share that the Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2023 has expanded its commercial support offerings to include a variety of sponsorship opportunities! Please see the comprehensive prospectus for full details.
If you are interested in exhibiting, please complete the Letter of Agreement.
If you have additional questions, please Contact: Joe Chanhthee
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.